期刊文献+

冠心病PCI术后再狭窄患者IL-18、IL-10和基质金属蛋白酶-9水平的研究 被引量:9

Study of interleukin-18,interleukin-10 and matrix metalloproteinase-9 levels in restenosis after percutaneous coronary intervention
下载PDF
导出
摘要 目的观察冠心病经皮冠状动脉介入治疗(PCI)术后再狭窄患者血清白细胞介素(IL)-18、IL-10和基质金属蛋白酶-9(MMP-9)水平,探讨炎性因子在冠心病PCI术后再狭窄中的作用。方法冠心病PCI术后患者,根据再次冠脉造影是否存在支架内再狭窄分为支架内再狭窄(ISR)组(n=68)和非再狭窄(非ISR)组(n=173),109例疑似但经冠脉造影排除冠心病的人群作为对照组。测定各组血清IL-18、IL-10和MMP-9浓度。结果 ISR组和非ISR组血清IL-18和MMP-9浓度明显高于对照组,而血清IL-10浓度则明显低于对照组;与非ISR组相比,ISR组血清IL-18和MMP-9水平明显增高,而IL-10浓度则明显降低,差异均有统计学意义(P<0.05)。结论 IL-18、IL-10和MMP-9与再狭窄有关,炎性反应可能是冠心病PCI术后再狭窄的重要影响因素之一。 Objective To investigate the levels of IL-18,IL-10 and MMP-9 in coronary heart disease(CAD)patients with instent restenosis(ISR)after percutaneous coronary intervention (PCI)treatment,so as to discuss the influence of inflammatory factors to ISR after PCI.Methods CAD patients with ISR after PCI were angiographically reevaluated and formed the ISR group(n=68)and the non-ISR group(n=173)based on the presence or absence of ISR.109 subjects without angiographic evidence of CAD formed a reference control group(control group).The plasma IL-18,IL-10 and MMP-9 concentrations of subjects were measured. Results The concentrations of serum IL-18 and MMP-9 in ISR group and non-ISR group were significantly higher than control group,while IL-10 level was the opposite.Contrasted with non-ISR group,the concentrations of serum IL-18 and MMP-9 in ISR group were significantly higher,but IL-10 level was the opposite too.There were significantly statistical differences(P 〈0.05)Con-clusion There is significant correlation between ISR and serum levels of IL-18,IL-10 and MMP-9.The inflammation may have important impact on the process of ISR.
出处 《国际检验医学杂志》 CAS 2014年第11期1431-1432,共2页 International Journal of Laboratory Medicine
关键词 白细胞介素-18 白细胞介素-10 基质金属蛋白酶-9 冠状动脉疾病 支架内再狭窄 interleukin-18 interleukin-10 matrix metalloproteinase-9 coronary artery disease in-stent restenosis
  • 相关文献

参考文献16

  • 1Libby P,Ridker PM, Maseri A. Inflammation and atherosclerosis [J]. Circulation, 2002,105(9) : 1135-1143.
  • 2Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes [J]. Heart,2002,87(3) :201-204.
  • 3Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med,2005,352(16) :1685-1695.
  • 4Packard RRS,Libby P. Inflammation in atheroselerosis: from vas cular biology to biomarker discovery and risk prediction[J]. Clin Chem,2008,54(1) :24-38.
  • 5Zernecke A,Shagdarsuren E,Weber C. Chemokines in atheroscle rosis an update[J]. Arterioscler Thromb Vasc Biol, 2008,28 (11) : 1897-1908.
  • 6Gaunt TR,Rodriguez S, Day I NM. Cubic exact solutions for the estimation of pairwise haplotype frequencies:implications for link age disequilibrium analyses and a web tool' CubeX' [J]. BMC Bioinformatics, 2007,8 (1) : 428.
  • 7Hoffmann R, Mintz GS. Coronary in-stent restenosis-predietors, treatment and prevention[J]. Euro Heart J, 2000,21 (21) : 1739-1749.
  • 8Mitra AK,Agrawal DK. In stent restenosis:bane of the stent era [J]. J Clin Pathol,2006,59(3) :232-239.
  • 9Maffia P,Grassia G,Di Meglio P,et al. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury[J]. Circulation, 2006,114(5) : 430-437.
  • 10Chandrasekar B, Vemula K, Surabhi RM, et al. Activation of in trinsic and extrinsic proapoptotic signaling pathways in interleukin-18 mediated human cardiac endothelial cell death[J]. J Biol Chem,2004,279(19) :20221-20233.

同被引文献129

  • 1李博,朱平先,吴清华.64排128层螺旋CT在冠状动脉与支架术后狭窄诊断中的应用价值[J].中华临床医师杂志(电子版),2012,6(20):167-169. 被引量:25
  • 2乔志强,张敏州,程康林.邓铁涛治疗急性心肌梗死介入术后医案一则[J].中医杂志,2005,46(3):231-232. 被引量:20
  • 3Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis[J].Lancet, 2007,370(9591):937-948.
  • 4ColomboA, LatibA. Treatment of drug eluting stent restenosis with another drug-eluting stent: do not fail the second time [J].Rev Esp Cardiol, 2008,61(11):1120-1122.
  • 5Bashore TM, Bate ER, Berger PB, et al. American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus on cardiac catheterization laboratory standards[J].Jam Cardiol, 2007,37(8):2170-2214.
  • 6LeschkaS, Alkadhi H, PlassA, et aT. Accuracy of MSCT coronary angiography with 64-slice technology: first experience[J]. Eur Heart J, 2011,26(15):1482-1487.
  • 7He M, Gong Y, Shi J, Pan Z, Zou H, et al. Plasma MicroRNhs as Potential Noninvasive Biomarkers for In-Stent Restenosis [J].PLoS ONE, 2014,9(11):e112043.
  • 8Kang SJ, Ming GS, Park DW, et al.Mechanisms of in-stent restenosisafter drug-eluting stent implantation: intravascular ultrasound analysis[J].Circ Cardiovasc Interv, 2011,4(1): 9-14.
  • 9Aronson D, Edelman ER. Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting[J].Rev Endocr Metab Disord, 2010,11(1):75-86.
  • 10Spadaccio C, Patti G, De Marco F, Pollari F, et al. Usefulness of preprocedural levels of advanced glycation end products topredict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris(from the Prospective ARMYDA-AGEs Study) [J].Am J Cardiol, 2013.112(1):21-26.

引证文献9

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部